Bicisate dihydrochloride

Base Information

• Chemical Name: Bicisate dihydrochloride
• CAS No.: 14344-58-2
• Molecular Formula: C12H24 N2 O4 S2 . 2 Cl H
• Molecular Weight: 397.38
• Hs Code.: 2930909090
• European Community (EC) Number: 630-819-4
• UNII: B005P07V07
• DSSTox Substance ID: DTXSID4046656
• Wikidata: Q27274207
• RXCUI: 1306099
• Mol file: 14344-58-2.mol

Synonyms:Bicisate dihydrochloride;14344-58-2;DTXSID4046656;UNII-B005P07V07;B005P07V07;Cysteine, N,N'-ethylenedi-, diethyl ester, dihydrochloride, L-;l-Cysteine, N,N'-1,2-ethanediylbis-, diethyl ester, dihydrochloride;l-Cysteine, N,N'-1,2-ethanediylbis-, 1,1'-diethyl ester, hydrochloride (1:2);(2R,2'R)-Diethyl 2,2'-(ethane-1,2-diylbis(azanediyl))bis(3-mercaptopropanoate) dihydrochloride;diethyl 2,2'-(ethane-1,2-diylbis(azanediyl))(2R,2'R)-bis(3-mercaptopropanoate) dihydrochloride;Ethyl (2R)-2-[2-[[(1R)-2-ethoxy-2-oxo-1-(sulfanylmethyl)ethyl]amino]ethylamino]-3-sulfanyl-propanoate dihydrochloride;Ecd;NCGC00167479-01;DTXCID10820014;Tox21_112483;MFCD08061488;AKOS017343961;BICISATE DIHYDROCHLORIDE [WHO-DD];Ethylene Dicysteine Diester (ECD) 2 HCl;CAS-14344-58-2;Q27274207;DIETHYL (2R,2'R)-2,2'-(ETHANE-1,2-DIYLDIIMINO)BIS(3-MERCAPTOPROPANOATE) DIHYDROCHLORIDE;ethyl (2R)-2-[2-[[(2R)-1-ethoxy-1-oxo-3-sulfanylpropan-2-yl]amino]ethylamino]-3-sulfanylpropanoate;dihydrochloride

Chemical Property of Bicisate dihydrochloride

Chemical Property:

• Flash Point: 195.7 °C
• PSA: 154.26000
• LogP: 2.27440
• Storage Temp.: -20°C
• Hydrogen Bond Donor Count: 6
• Hydrogen Bond Acceptor Count: 8
• Rotatable Bond Count: 13
• Exact Mass: 396.0711050
• Heavy Atom Count: 22
• Complexity: 265

Purity/Quality:

99%, ^*data from raw suppliers

ECD ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CCOC(=O)C(CS)NCCNC(CS)C(=O)OCC.Cl.Cl
• Isomeric SMILES: CCOC(=O)[C@H](CS)NCCN[C@@H](CS)C(=O)OCC.Cl.Cl
• Uses: C143440 is radiopharmaceutical. Radiopharmaceutical is radioactive drug used for diagnosis or therapy in a tracer quantity with no pharmacological effect. The radiopharmaceuticals discussed include US Food and Drug Administration (FDA) approved tracers as well as those currently undergoing clinical trials that have yet to obtain FDA approval.